Atrial fibrillation (AFib) happens when your heart’s upper chambers beat chaotically and out-of-synch with its lower chambers, resulting in an irregular and very rapid heartbeat. If prolonged and left untreated, AFib can lead to blood clots and increase the risk of stroke and heart-related complications.1
We are currently recruiting participants for the AFib Device Study, assessing the effectiveness of a non-invasive medical device to detect an irregular heartbeat.
You may qualify for the AFib Study if you:
- Are 22 years of age or older
- Have been diagnosed with permanent or persistent atrial fibrillation
- Do not have an implanted medical device (with exception of a glucose monitor)
There is no cost to take part in the AFib Device Study, and study care is provided at no cost and overseen by experienced medical professionals. Qualified patients that complete the study visit will be compensated $300. Support for travel is available. No health insurance is required.
Sign Up
What happens if I fill out the pre-screening questionnaire? If you pass the initial study screener, we will match you to a AFib Device Study location in your area that needs volunteers with atrial fibrillation or notify you when one becomes available. If there is not a current study in your area, a Patient Engagement Specialist may reach out to you in the future via the email address or phone number (call or text) you provided to share information about new study opportunities you may qualify for.
Keep in mind that participation is entirely voluntary.
About Atrial Fibrillation
Atrial fibrillation (AFib) happens when your heart’s upper chambers beat chaotically and out-of-synch with its lower chambers, resulting in an irregular and very rapid heartbeat. If prolonged and left untreated, AFib can lead to blood clots and increase the risk of stroke and heart-related complications.1
Symptoms of AFib include:
- Heart palpitations
- Chest pain
- Weakness and/or fatigue
- Dizziness or light-headedness
- Shortness of breath2
Some conditions can damage your heart’s electrical system, resulting in AFib; however, in some cases, AFib has no identifiable cause. Possible contributing factors include:
- Heart disease (coronary artery disease, heart valve disease, heart failure, cardiomyopathy, pericarditis, and birth defects)
- Long-term high blood pressure
- Hypokalemia (low potassium)
- Increased age (60+)
- Genetics
- Ethnicity (people of European descent have a higher rate of AFib)
- Gender (female)3
Frequently Asked Questions
What is a clinical research study?
A clinical research study (also called a clinical trial) is a medical study that helps to answer important questions about an investigational drug or vaccine—these may include how well an investigational study drug or vaccine works for a certain condition. All medications and medical devices must be tested in clinical research studies before they can be approved and prescribed to patients.
Why are clinical research studies important?
A clinical research study is the process by which new and innovative medications, interventions, devices, and treatments are approved and brought to market, so people can live happier and healthier lives.
Even over-the-counter medications, such as NSAIDs, you may have used to counteract a headache, have gone through the clinical research study process before it was available at your local pharmacy.
Will I be reimbursed?
Qualified patients that complete the study visit will be compensated $300. Support for travel is available. Please discuss this with the study team when they contact you.
What else do I need to consider?
The research team will be able to explain more about what the AFib Device Study will involve, and it is up to you to decide if you want to take part. Participation in this study is voluntary. Whether or not you decide to participate in this study will not affect your current or future relationships with your doctors. If you decide to participate, you are free to withdraw at any time without affecting those relationships.
How far is the study site?
We will match you to a study site within a close travel distance from your home. If we are not running the study in your area currently, with your permission, we will keep you in our database and reach out once a study in your area becomes available. If, at any time, you decide you no longer want your information stored, you can opt out and we will delete your details.
About the AFib Device Study
The AFib Device Study is looking to enroll approximately 384 people, with permanent or persistent atrial fibrillation, at sites across the United States. The study is testing a non-invasive device to detect atrial fibrillation. This study only requires one visit to the study site and no follow up is required.
During this time, a dedicated medical team will provide participants with all study-related care at no cost. Qualified patients that complete the study visit will be compensated $300. Support for travel is available. No insurance is required.
Who can participate?
You may be able to take part in the AFib Device Study if you:
- Are 22 years of age or older
- Have been diagnosed with permanent or persistent atrial fibrillation
- Do not have an implanted medical device (with exception of a glucose monitor)
The study will be evaluating the safety and effectiveness of an investigational medical device designed to detect an irregular heartbeat.